NCT04369391View on ClinicalTrials.gov

A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.

PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

November 10, 2020

Study Completion Date

November 10, 2020

Conditions
Schizophrenia
Interventions
DRUG

SEP363856 150 mg

SEP363856 tablet 150 mg

DRUG

Placebo

Placebo tablet

DRUG

moxifloxacin 400 mg

moxifloxacin tablet 400 mg

Trial Locations (7)

33024

Research Centers of America, LLC, Hollywood

72211

Woodland International Research Group, Little Rock

78754

Community Clinical Research Inc. Austin, TX 78754, Austin

90660

California Neuropsychopharmacology Clinical Research Institute-LA, LLC (CNRI-LA, LLC), Pico Rivera

90806

Collaborative Neuroscience Research, LLC, Long Beach

92101

California Neuropsychopharmacology Clinical Research Institute-San Diego, LLC (CNRI-SD, LLC), San Diego

08053

Hassman Research Institute, Marlton

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT04369391 - A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia. | Biotech Hunter | Biotech Hunter